Infliximab (Remicade^®) for Acute, Severe Pustular and Erythrodermic Psoriasis

By Lisby Steen   Gniadecki Robert  

Acta Dermato-Venereologica, Vol. 84, Iss. 3, 2004-05 ,pp. : 247-248

Medical Journals Limited

Access to resources Recommend Favorite

Palmoplantar Pustular Psoriasis: Successful Therapy with Efalizumab after Non-response to Infliximab

By Wozel Gottfried   Vitéz Lilla  

Acta Dermato-Venereologica, Vol. 88, Iss. 2, 2008-01 ,pp. : 169-170

Medical Journals Limited

Access to resources Recommend Favorite

A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept

By Lynde Charles W.   Gupta Aditya K.   Guenther Lyn   Poulin Yves   Levesque Annie   Bissonnette Robert  

Journal of Dermatological Treatment, Vol. 23, Iss. 4, 2012-08 ,pp. : 261-267

Informa Healthcare

Access to resources Recommend Favorite

Psoriasis and psoriatic arthritis induced in a patient treated with infliximab for Crohn’s disease

By Tichy Martin   Tichy Martin   Kopova Renata   Sternbersky Jan   Ditrichova Dagmar  

Journal of Dermatological Treatment, Vol. 23, Iss. 3, 2012-06 ,pp. : 208-211

Informa Healthcare

Access to resources Recommend Favorite

Entecavir and Intermittent Etanercept Therapy in a Patient with Concurrent Hepatitis B Virus Infection and Psoriasis

By Babino Graziella   Esposito Maria   Mazzotta Annamaria   Chimenti Sergio   Giunta Alessandro  

Acta Dermato-Venereologica, Vol. 93, Iss. 3, 2013-03 ,pp. : 373-374

Medical Journals Limited

Access to resources Recommend Favorite